Clinical Trial

Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a randomized, double-blinded, placebo-controlled trial to compare the effectiveness of IV oxytocin infusion to placebo on peri-operative opioid consumption and reducing post-operative pain following a minimally invasive hysterectomy under general anesthesia.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-07-01 -> 2027-12-31 2026-08-14
minor Completion pushed: 2026-12-01 -> 2028-06-30 2026-08-14
Trial Details
NCT Number NCT06483659
Lead Sponsor Brigham and Women's Hospital
Conditions Postoperative Pain
Enrollment 152 participants
Start Date 2025-06-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-13